RESUMEN
OBJECTIVES: The modern three-piece inflatable penile prosthesis (IPP) has undergone multiple revisions since its introduction in 1973. We reviewed devices placed since the last major revision by American Medical Systems (AMS) in 1987. METHODS: A retrospective chart review was refined with data from an independent patient and partner survey. RESULTS: Two hundred twelve consecutive penile prosthetic devices placed by a single surgeon over an 8-year period are reviewed. One hundred sixty-nine of the devices were three-piece inflatables with 146 being primary implants. The average device has been in place 36.5 months (range 9 to 102). The infection rate in 146 primary three-piece devices was 2.1%. The infection rate in 46 secondary implants or revisions was 6.5%, excluding seven salvage attempts. Mechanical failure in 122 primary AMS devices placed was 4.1%. Mechanical failure in 24 Mentor devices was 4.2% if one discounts connector failures that were revised in 1990. A surgical complication and revision rate of 1.4% was noted in the 146 primary implants. An independent telephone survey achieved a 57% and 24% response rate in patients and partners with three-piece devices placed. In the group of 86 patients with a primary three-piece device placed and complete follow-up, the probability of having a normally functioning device placed in a single operative procedure was 90.6% at 3 years. On a 1 to 10 scale looking at all primary devices, secondary devices, revisions, and infections, the average and median satisfaction rate was as follows: 8.2, 8.5; 8.4, 9.0; 7.7, 7.75 for the Ultrex patients, CX 700 and Mentor patients, and all partners, respectively. CONCLUSIONS: The modern three-piece IPP is an excellent surgical option offering a very safe, reliable return to sexual activity for our patients.
Asunto(s)
Satisfacción del Paciente , Prótesis de Pene , Estudios de Evaluación como Asunto , Humanos , Masculino , Prótesis de Pene/efectos adversos , Diseño de Prótesis , Falla de Prótesis , Infecciones Relacionadas con Prótesis/epidemiología , Infecciones Relacionadas con Prótesis/etiología , Reoperación , Estudios Retrospectivos , Encuestas y Cuestionarios , Factores de TiempoRESUMEN
Autoinflation of a penile prosthetic device can be a frustrating experience for the patient and surgeon alike. Although there are many causes of autoinflation, elevated reservoir pressure at the time of surgical placement is one of the more common etiologies. We describe a simple, quick technique to quantitate reservoir pressures and volume, preventing pressures that could lead to autoinflation.
Asunto(s)
Prótesis de Pene , Falla de Prótesis , Humanos , Masculino , Presión , Procedimientos Quirúrgicos Operativos/métodosRESUMEN
PURPOSE: Controversy exists concerning the need for routine endocrine screening in impotent men. Debate also continues as to what hormonal studies are necessary, the role of the free fraction of testosterone and whether a history of decreased libido or testicular atrophy can predict these endocrinopathies. MATERIALS AND METHODS: We reviewed 508 consecutive men who presented with sexual dysfunction within a 22-month period. Testosterone data were available for 268 patients (53%) and prolactin data were available for 170 (33%). RESULTS: Hypogonadism, defined as 2 abnormal total testosterone levels, was found in 42 of our 268 patients (15.6%). A history of decreased libido by patient questionnaire and/or testicular atrophy on physical examination could not predict these cases. A normal free fraction of testosterone saved further unnecessary endocrine evaluation in 50% of patients with hypogonadism. Hypoprolactinemia was noted in 3 of 170 patients (1.8%). CONCLUSIONS: Routine endocrine screening remains a necessary part of the evaluation for sexual dysfunction. A history of decreased libido and/or testicular atrophy on physical examination cannot predict hypogonadism. Measurement of free fraction of testosterone will further lessen unnecessary endocrine evaluations by 50% and should become standard practice in screening for hypogonadism. Prolactin levels are necessary only in patients with hypogonadism and/or a history of decreased libido.
Asunto(s)
Disfunción Eréctil/sangre , Hipogonadismo/diagnóstico , Testosterona/sangre , Adulto , Anciano , Anciano de 80 o más Años , Disfunción Eréctil/etiología , Humanos , Hipogonadismo/sangre , Hipogonadismo/complicaciones , Hormona Luteinizante/sangre , Masculino , Persona de Mediana Edad , Prolactina/sangreRESUMEN
The widespread use of penile injections in the management of erectile dysfunction has led to an increased incidence of priapism. It has been suggested that terbutaline, a beta-agonist, might be beneficial in treating priapism in this setting. We randomized 24 patients with prolonged erections to a prospective, double-blind, placebo-controlled trial. We did not find any benefit of oral terbutaline over placebo in these patients.
Asunto(s)
Priapismo/tratamiento farmacológico , Terbutalina/uso terapéutico , Administración Oral , Método Doble Ciego , Humanos , Masculino , Estudios Prospectivos , Terbutalina/administración & dosificaciónRESUMEN
A group of 170 impotent men achieved usable erections during a 26-month period with a combination of papaverine, phentolamine and prostaglandin E1 (triple-drug therapy) injected intracorporeally. Of the patients 146 elected to enter a pharmacological erection program using this combination. Patient age ranged from 24 to 85 years and the average duration on the program was 11.2 months. Average injection volume was 0.36 cc per injection (range 0.1 to 1). Among those patients managed by our nurse clinician, only 3 episodes of priapism were encountered (1.7%). Scarring was documented in 7 of 170 patients (4.2%) 1 week to 21 months after starting the injections. Pain was encountered in 6 of 170 patients (3.5%). A superior dose response coupled with a low incidence of priapism, pain and scarring have led us to use triple-drug therapy as our agent of choice in the pharmacological management of erectile dysfunction.
Asunto(s)
Alprostadil/administración & dosificación , Disfunción Eréctil/tratamiento farmacológico , Papaverina/administración & dosificación , Erección Peniana/efectos de los fármacos , Fentolamina/administración & dosificación , Adulto , Anciano , Anciano de 80 o más Años , Alprostadil/uso terapéutico , Cicatriz/etiología , Costos y Análisis de Costo , Combinación de Medicamentos , Humanos , Masculino , Persona de Mediana Edad , Papaverina/uso terapéutico , Pene/patología , Fentolamina/uso terapéutico , Priapismo/inducido químicamente , AutoadministraciónRESUMEN
A comprehensive multidisciplinary evaluation was carried out on 300 outpatients seen consecutively at a specialized impotence center. Psychologic evaluation was coupled with the use of contemporary diagnostic modalities. Nocturnal penile tumescence testing, penile vascular studies, pharmacologic diagnostic testing and dynamic infusion cavernosography have been used advantageously. In addition to psychologic counseling for all treatment categories, treatment alternatives have included hormonal and pharmacologic agents and penile prosthetic implantations.
Asunto(s)
Instituciones de Atención Ambulatoria , Disfunción Eréctil/terapia , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Evaluación como Asunto , Humanos , Masculino , Persona de Mediana Edad , Disfunciones Sexuales Psicológicas/terapiaRESUMEN
Pharmacological erection is becoming an accepted form of treatment in the impotent patient. We report on our experience in 69 men with organic and psychogenic etiologies using intracorporeal injection with a mixture of papaverine hydrochloride and phentolamine mesylate. A good response was achieved in all patients except those with severe arterial or venous insufficiency. Although it was used primarily in cases of organic impotence, we found intracorporeal injection to be valuable in the patient with psychogenic impotence as an adjunct to sex therapy. Auto-injection was practiced by 74 per cent of our patients with a good response and 50 per cent noticed subjective improvement in the ability to obtain natural erections. Priapism was the most significant complication and occurred in 8.7 per cent of the patients. However, most patients have expressed satisfaction with this alternative to penile implantation.